上海澳斯康生物制药有限公司

Chinese biopharmaceutical company in Shanghai belonging to the Thousand Oaks Biologics group, an integrated CMC business built around cell culture media and CDMO services whose main entity is Thousand Oaks Biologics (Nantong). The group also comprises Jianshun Biotechnology in Nantong and Gansu, Jianshibai Biotechnology in Shanghai and Thousand Oaks Biopharmaceuticals in the United States, with production bases and research laboratories in Nantong, Shanghai, Lanzhou and the San Francisco Bay Area. Aims to be a leader combining raw materials, consumables, pharmaceutical equipment, technical services and contract manufacturing for the Chinese biopharmaceutical industry, offering one stop CMC solutions from candidate molecule through clinical and commercial manufacture for monoclonal and bispecific antibodies, fusion proteins and antibody drug conjugates, and has passed quality audits to Chinese NMPA, United States FDA and European EMA standards.